ADMA Biologics Inc $ 3.57 -0.17 (-4.55%)
Warning! GuruFocus has detected 7 Severe warning signs with ADMA. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for ADMA Biologics Inc () from 2013 to Aug 03 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. ADMA Biologics stock (ADMA) PE ratio as of Aug 03 2020 is 0. More Details
ADMA Biologics PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
ADMA Biologics PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:LQDA NAS:SPRO NAS:ABEO NAS:FBIO NAS:ADRO OTCPK:NWBO NAS:NYMX NAS:GRTS NAS:AVXL NYSE:RFL OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Traded in other countries ADMA.USA
Address 465 State Route 17, Ramsey, NJ, USA, 07446
ADMA Biologics Inc is a United States-based biopharmaceutical company. It is engaged in the manufacture, marketing and development of specialty plasma-derived biologics. The operating segments of the company are ADMA BioManufacturing segment; Plasma Collection Centers segment; and Corporate segment. The Plasma Collection Centers segment consists of three FDA-licensed source plasma collection facilities located in Georgia. The company's ADMA BioManufacturing segment reflects the company's immune globulin manufacturing and development operations in Florida. It derives a majority of the revenue from the Plasma Collection Centers.